Nanexa announces that all patients have now been included in the fourth and final dose cohort in the Phase I study of NEX-22, a one-month formulation of liraglutide. NEX-22 is a new promising ...

If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...

The popular antidepressant has been linked to weight gain, but experts say there are many factors that affect whether that ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

101 to 300 mg 5 to 1 20.0 301 to 600 mg 10 to 1 10.0 601 to 800 mg 12 to 1 8.3 801 to 1,000 mg 15 to 1 6.7 ≥ 1,001 mg 20 to 1 5.0 Morphine PO 30 mg 1 250 mg/d MOR = 250 × 2/30 = 17 mg/d MET ...